Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Dra. Irina Zaidman especializa-se em transplante de medula óssea pediátrica – um tratamento crítico para a anemia aplástica – no Hadassah Medical Center.
Realização de mais de 3.500 transplantes de medula óssea – reconhecido pela Forbes como um dos melhores médicos em 2018.
O Professor Bosch é um líder de renome mundial em Leucemia Linfocítica Crónica (LLC), com mais de 100 artigos publicados e participação contínua em mais de 80 ensaios clínicos.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
O Prof. Dr. Serdar Bedii Omay publicou mais de 65 artigos científicos sobre hematologia – focados em tratamentos avançados no Hospital Emsey.
O Dr. Apak é especialista em hematologia-oncologia pediátrica com mais de 30 anos de experiência, concentrando-se em transplante de medula óssea e terapia com células CAR-T no Hospital Universitário Biruni.
O Professor Associado Rafet Eren é especialista em hematologia, com mais de 50 publicações em periódicos internacionais, refletindo uma profunda experiência em distúrbios sanguíneos.
O Prof. Fabio Ciceri lidera a Unidade de Hematologia e Transplante de Medula Óssea do Hospital de Pesquisa San Raffaele – um centro especializado em terapias avançadas para distúrbios sanguíneos.
O Prof. Baytan especializa-se em hematologia e oncologia pediátrica, com foco em cancros infantis e transplantes de medula óssea no Hospital Emsey.
Especialista em leucemia crónica e doenças mieloproliferativas, o Dr. Dogu traz uma vasta experiência em hematologia para o Liv Hospital Ulus.
O Professor Associado Ali Hakan Kaya é especialista em hematologia e transplantes de células estaminais, com formação abrangente nos principais hospitais turcos.
O Dr. Eduardo Fernandez é um dos apenas 50 especialistas certificados em células-tronco no México, reconhecido pelo seu conhecimento avançado em medicina regenerativa.
Especializada em distúrbios de falência da medula óssea, a Dra. Itir Sirinoglu Temiz lidera o departamento de hematologia do Liv Hospital Vadistanbul.
Mais de 20 anos de especialização em hematologia pediátrica – o Dr. López-Ibor lidera a Unidade de Hematologia e Oncologia Pediátrica do HM Montepríncipe.